Primary Signet Ring Cell Carcinoma of the Prostate: A Rare Case Report.

Autor: Gök A; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. alper_gok@hotmail.com., Tuygun C; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. drct36@gmail.com., Akmansu M; Department of Radiation Oncology, Gazi University Medical Faculty, Ankara 06560, Turkey. igk84@hotmail.com., Uslu AA; Department of Pathology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. guluslu@gmail.com., Kartal IG; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. igk84@hotmail.com., Sandikçi F; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. drfatihsandikci61@hotmail.com., Karabacak OR; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. osmanraifkarabacak@mynet.com., Sağnak AL; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. leventsagnak@gmail.com., Topaloğlu H; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. hikmettopaloglu@hotmail.com., Ersoy H; Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. hamitersoy@gmail.com.
Jazyk: angličtina
Zdroj: Journal of clinical medicine [J Clin Med] 2018 Aug 15; Vol. 7 (8). Date of Electronic Publication: 2018 Aug 15.
DOI: 10.3390/jcm7080218
Abstrakt: Primary prostatic signet ring cell carcinoma is a rare form of cancer with a poor prognosis, which is generally treated with a traditional prostate adenocarcinoma therapy. This case report presents a 70-year-old diagnosed with primary prostatic signet ring cell carcinoma, treated with a combination of radiotherapy and hormone therapy and a 16 month survival without an evidence of the disease at follow up.
Competing Interests: The authors declare no conflict of interest.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje